Search

everythinglearnresearchcommunity

for

Search:↓

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

COVID-19 recovery can lead to temporary hair loss called telogen effluvium.

Zinc is crucial for nutrition, especially in patients with specific health conditions, and requires careful supplementation and monitoring.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Childhood ptosis can vary from a minor cosmetic issue to a serious condition and may signal other health problems.

Henna has potential health benefits and can treat various conditions, but more research is needed to confirm safety and effectiveness.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

Some patients developed skin inflammation after obesity surgery, and a medication called dapsone helped treat it.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Antiandrogen therapy helped increase hair growth in women with hormonal imbalances related to baldness.

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

Chemotherapy can cause various skin reactions, with hair loss being the most common, and proper diagnosis and treatment of these reactions are important.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

HIV can cause unusual and severe skin problems that are hard to treat.

Severe COVID-19 may cause hair loss, and doctors recommend supplements and topical treatments to manage it.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

COVID-19 may harm male fertility and damage the reproductive system.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

COVID-19 patients may experience hair loss, but it's not linked to their age or sex.